Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NIROGACESTAT HYDROBROMIDE vs NITRAZEPAM: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NIROGACESTAT HYDROBROMIDE vs NITRAZEPAM: Safety Overview

Metric	NIROGACESTAT HYDROBROMIDE	NITRAZEPAM
Total FAERS Reports	166	1,165
Deaths Reported	0	365
Death Rate	N/A	31.3%
Hospitalizations	18	466
Average Patient Age	46.8 yrs	51.2 yrs
% Female Patients	63.0%	54.1%
FDA Approval Date	Apr 4, 2024	N/A
Marketing Status	Prescription	N/A